Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42e94091a4fc81b8d0237117707cc7ee |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 |
filingDate |
1992-10-23^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
1997-03-26^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3ddb127229a011489eea6ad6154bfb0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10e76062830046b504deab925a794d31 |
publicationDate |
1997-03-26^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-0538897-B1 |
titleOfInvention |
The use of BMY 14802 in the treatment of anxiety in benzodiazepine-withdrawn patients |
abstract |
A method of treatment of anxiety in benzodiazepine-withdrawn patients by administering BMY 14802; chemically 4-Ä4-(5-fluoro-2-pyrimidinyl)-1-piperazinylÜ-1-(4-fluorophenyl) butanol, or preferably, the R-(+)- enantiomer to a patient in need of such treatment. |
priorityDate |
1991-10-24^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |